Cyteir Therapeutics Inc.

NASDAQ: CYT · Real-Time Price · USD
3.02
-0.07 (-2.27%)
At close: Mar 15, 2024, 9:00 PM

Cyteir Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
147.12M 189.72M
Short-Term Investments
n/a n/a
Long-Term Investments
n/a 256K
Other Long-Term Assets
2.32M n/a
Receivables
n/a n/a
Inventory
n/a -38K
Other Current Assets
2.09M 3.35M
Total Current Assets
149.21M 193.08M
Property-Plant & Equipment
1.7M 2.06M
Goodwill & Intangibles
n/a n/a
Total Long-Term Assets
4.02M 2.31M
Total Assets
153.23M 195.39M
Account Payables
1.13M 1.78M
Deferred Revenue
n/a n/a
Short-Term Debt
889K n/a
Other Current Liabilities
3.3M 5.73M
Total Current Liabilities
5.32M 7.51M
Long-Term Debt
n/a n/a
Other Long-Term Liabilities
1.63M 585K
Total Long-Term Liabilities
1.63M 585K
Total Liabilities
6.95M 8.1M
Total Debt
889K n/a
Common Stock
35K 35K
Retained Earnings
-138.11M -92.05M
Comprehensive Income
n/a -195.39M
Shareholders Equity
146.29M 187.29M
Total Investments
n/a 256K